{"cik":906338,"taxonomy":"us-gaap","tag":"DeferredIncomeTaxAssetsNet","label":"Deferred Income Tax Assets, Net","description":"Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.","entityName":"TARO PHARMACEUTICAL INDUSTRIES LTD","units":{"USD":[{"end":"2019-03-31","val":110974000,"accn":"0001564590-20-029846","fy":2020,"fp":"FY","form":"20-F","filed":"2020-06-19","frame":"CY2019Q1I"},{"end":"2020-03-31","val":106693000,"accn":"0001564590-20-029846","fy":2020,"fp":"FY","form":"20-F","filed":"2020-06-19"},{"end":"2020-03-31","val":106693000,"accn":"0001564590-21-033341","fy":2021,"fp":"FY","form":"20-F","filed":"2021-06-17","frame":"CY2020Q1I"},{"end":"2021-03-31","val":142007000,"accn":"0001564590-21-033341","fy":2021,"fp":"FY","form":"20-F","filed":"2021-06-17"},{"end":"2021-03-31","val":142007000,"accn":"0000950170-22-012998","fy":2022,"fp":"FY","form":"20-F","filed":"2022-07-25","frame":"CY2021Q1I"},{"end":"2022-03-31","val":124882000,"accn":"0000950170-22-012998","fy":2022,"fp":"FY","form":"20-F","filed":"2022-07-25"},{"end":"2022-03-31","val":124882000,"accn":"0000950170-23-030778","fy":2023,"fp":"FY","form":"20-F","filed":"2023-06-29","frame":"CY2022Q1I"},{"end":"2023-03-31","val":103672000,"accn":"0000950170-23-030778","fy":2023,"fp":"FY","form":"20-F","filed":"2023-06-29","frame":"CY2023Q1I"}]}}